What is the recommended dosage and treatment regimen for Tazarotene (Tazarotene)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tazarotene Dosage and Treatment Regimen

For the treatment of acne vulgaris and plaque psoriasis, tazarotene should be applied as a thin film once daily in the evening to affected areas only. 1

Dosing Guidelines

For Acne Vulgaris:

  • Apply a thin layer (2 mg/cm²) of tazarotene 0.1% cream once daily in the evening to the skin areas where acne lesions appear 1
  • Cleanse the face gently and ensure skin is completely dry before application 1
  • Use enough to cover the entire affected area 1
  • Safety and effectiveness have not been established in pediatric patients under 12 years of age 2

For Plaque Psoriasis:

  • Apply a thin film (2 mg/cm²) of tazarotene 0.1% cream once daily in the evening to cover only the psoriatic lesions 1
  • If a bath or shower is taken prior to application, ensure the skin is completely dry before applying the cream 1
  • If emollients are used, they should be applied at least one hour before application of tazarotene cream 1
  • Avoid application to unaffected skin, as it may be more susceptible to irritation 1

Combination Therapy Recommendations

For Psoriasis:

  • The combination of tazarotene with medium- or high-potency topical corticosteroids for 8-16 weeks is more effective than tazarotene monotherapy and is recommended for the treatment of mild to moderate psoriasis (strength of recommendation: A) 2
  • This combination therapy increases efficacy while reducing local adverse events 2
  • The combination also increases the duration of treatment effect and extends remission time 2

For Nail Psoriasis:

  • Tazarotene 0.1% cream can be used for nail psoriasis, particularly when applied under occlusion 3
  • Has shown significant improvement in the Nail Psoriasis Severity Index with respect to onycholysis, pitting, hyperkeratosis, and oil spots 2

Managing Side Effects

  • Common adverse effects include pruritus, burning, skin redness, peeling, desquamation, dry skin, and erythema 2, 4
  • Side effects are most common during the first 1-2 weeks of therapy 4
  • To minimize irritation:
    • Use the cream formulation instead of gel 4
    • Consider alternate-day application if irritation is severe 4
    • Use short contact therapy (30-60 minutes) 2
    • Apply in combination with moisturizers 2
    • Use mild cleansers 4
    • Consider combination with topical corticosteroids to reduce irritation 2, 4

Important Precautions

  • Pregnancy category X: Tazarotene is contraindicated during pregnancy 2
  • Women of childbearing potential should have a negative pregnancy test within 2 weeks prior to starting treatment 1
  • Therapy should begin during a menstrual period 1
  • Avoid exposure to sunlight, sunlamps, and weather extremes; wear sunscreen daily 2, 1
  • Not for ophthalmic, oral, or intravaginal use 1
  • If contact with eyes occurs, rinse thoroughly with water 1

Pharmacokinetics

  • Tazarotene is rapidly hydrolyzed by esterases to its active metabolite, tazarotenic acid 5
  • Systemic bioavailability is low (approximately 1% in healthy skin, up to 5% in psoriatic skin) 5
  • Steady-state concentrations are achieved within 2 weeks of topical treatment 5
  • The drug is rapidly eliminated via urinary and fecal pathways with a terminal half-life of about 18 hours 5

Treatment Duration

  • For acne, if there is no improvement after 12 weeks, treatment should be reassessed 6, 7
  • For psoriasis, clinical trials have shown significant improvement with 12 weeks of treatment 8

By following these dosing guidelines and taking appropriate precautions, tazarotene can be an effective treatment for both acne vulgaris and plaque psoriasis.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.